Psychedelics and DMT
DMT (N,N-Dimethyltryptamine) is a powerful psychedelic compound used both in traditional shamanic practices and emerging clinical research for mental health and neuroplasticity.
Overview
| Attribute |
Description |
| Full Name |
N,N-Dimethyltryptamine |
| Class |
Tryptamine psychedelic |
| Mechanism |
5-HT2A receptor agonist |
| Duration |
5-30 minutes (when smoked/injected) |
| Legal Status |
Controlled substance in most jurisdictions |
What Is DMT?
Chemical Nature
- Structurally similar to serotonin
- Found naturally in many plants
- Detectable in trace amounts in human body
- Function in human biology unclear
Traditional Use
- Ayahuasca: Amazonian brew containing DMT + MAOI
- Shamanic ceremonies for healing and divination
- Thousands of years of traditional use
Effects
Subjective Experience
| Aspect |
Description |
| Visual |
Intense geometric patterns, vivid colors |
| Entity Contact |
"Machine elves," autonomous beings |
| Ego Dissolution |
Loss of self-boundary |
| Time Distortion |
Subjective time dilation |
| Mystical |
Sense of profound meaning, unity |
The "Entity" Phenomenon
- Many users report encountering seemingly autonomous beings
- Described as "machine elves," "guides," or "aliens"
- Consistent across cultures and individuals
- Scientific explanation unclear (neural vs. ontological)
Clinical Research
Therapeutic Applications
| Condition |
Research Status |
Findings |
| Depression |
Phase II trials |
Rapid, sustained improvement |
| PTSD |
Early research |
Promising results |
| Anxiety |
Clinical studies |
Reduced end-of-life anxiety |
| Addiction |
Pilot studies |
Reduced substance use |
Johns Hopkins Studies
- Center for Psychedelic and Consciousness Research
- Rigorous double-blind protocols
- Long-term follow-up showing sustained benefits
Mechanism of Action
Primary Target
- 5-HT2A receptor agonist (serotonin receptor subtype)
- Disrupts default mode network (DMN)
- DMN associated with self-referential thinking
Neuroplasticity
- Promotes dendritic spine growth
- Enhances neural connectivity
- "Resets" maladaptive patterns
Biohacking Context
Why Biohackers Are Interested
| Goal |
Rationale |
| Neuroplasticity |
Reset entrenched thought patterns |
| Creativity |
Access novel cognitive states |
| Death acceptance |
Reduce mortality anxiety |
| Self-optimization |
Explore consciousness limits |
Bryan Johnson's Interest
- Discussed on All-In Podcast
- Views psychedelics as tools for consciousness expansion
- Part of broader "Don't Die" philosophy
- Separates recreational from therapeutic use
Risks and Considerations
Psychological Risks
| Risk |
Description |
| Bad trips |
Intense anxiety, fear |
| HPPD |
Persistent visual disturbances |
| Psychosis trigger |
Risk for predisposed individuals |
| Integration challenges |
Difficulty processing experience |
Contraindications
- MAOIs: Dangerous interaction
- SSRIs: Reduced effects, serotonin syndrome risk
- Personal/family history of psychosis
- Cardiovascular conditions
Legal Landscape
Current Status
- US: Schedule I controlled substance
- Most countries: Illegal or heavily restricted
- Religious exceptions: Some ayahuasca churches
- Research: Permitted in approved studies
Decriminalization Trends
- Oregon, Colorado: Psilocybin legalization
- Various cities: Decriminalization measures
- DMT-specific policy slower to change
Related